Skip to main content
. 2018 Dec 8;19(12):3945. doi: 10.3390/ijms19123945

Figure 3.

Figure 3

Positive correlation of CMV-specific ELISpot results in kidney transplant recipients. (a) indicates results after stimulation with CMV phosphoprotein 65 (pp65), (b) after stimulation with CMV immediate early antigen 1 (IE-1) and (c) after stimulation with both CMV antigens. This Spearman correlation analysis considers 77 CMV IgG positive kidney transplant recipients and includes one data set per patient, as specified in the Materials and Methods section. Further details on this analysis are given in Table S1 (Supplement).